Pharmacy Practice and Administration
The scope of the Special Issue is research and reviews on evaluations of current practice, innovations in medication management, developments in therapeutics, and pharmaceutical science research that informs and improves practice and administration, as well as the social and administrative pharmacy....
Format: | eBook |
---|---|
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
Subjects: | |
Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
LEADER | 05608namaa2201717uu 4500 | ||
---|---|---|---|
001 | doab91187 | ||
003 | oapen | ||
005 | 20220812 | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 220812s2022 xx |||||o ||| 0|eng d | ||
020 | |a 9783036547299 | ||
020 | |a 9783036547305 | ||
020 | |a books978-3-0365-4729-9 | ||
024 | 7 | |a 10.3390/books978-3-0365-4729-9 |2 doi | |
040 | |a oapen |c oapen | ||
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a KND |2 bicssc | |
072 | 7 | |a M |2 bicssc | |
720 | 1 | |a Adunlin, Georges |4 edt | |
720 | 1 | |a Adunlin, Georges |4 oth | |
245 | 0 | 0 | |a Pharmacy Practice and Administration |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 online resource (260 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
520 | |a The scope of the Special Issue is research and reviews on evaluations of current practice, innovations in medication management, developments in therapeutics, and pharmaceutical science research that informs and improves practice and administration, as well as the social and administrative pharmacy. We will mainly feature original research, reviews, short reports, and clinical studies, but also case reports, descriptive/how-to, and commentary submissions for consideration. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Manufacturing industries |2 bicssc | |
650 | 7 | |a Medicine and Nursing |2 bicssc | |
653 | |a ability | ||
653 | |a abuse | ||
653 | |a acute care | ||
653 | |a additional monitoring | ||
653 | |a adolescents and young adults | ||
653 | |a adverse drug events | ||
653 | |a adverse event reporting | ||
653 | |a ambulatory care facilities | ||
653 | |a antimicrobial resistance (AMR) | ||
653 | |a asynchronous learning | ||
653 | |a attitudes | ||
653 | |a availability | ||
653 | |a awareness | ||
653 | |a barriers | ||
653 | |a biosensing technology | ||
653 | |a black triangle | ||
653 | |a business | ||
653 | |a cancer patients | ||
653 | |a Chief Pharmaceutical Officer's Global Health Fellowship | ||
653 | |a Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) | ||
653 | |a community pharmacies | ||
653 | |a community pharmacists | ||
653 | |a community pharmacy | ||
653 | |a community pharmacy services | ||
653 | |a contraception | ||
653 | |a COVID-19 | ||
653 | |a CPhOGH Fellows | ||
653 | |a CwPAMS | ||
653 | |a decision to study in pharmacy | ||
653 | |a defined daily dose | ||
653 | |a digital medicine system | ||
653 | |a drug disposal | ||
653 | |a drug-related problems | ||
653 | |a e-prescription | ||
653 | |a emergency contraception | ||
653 | |a emergency contraceptives | ||
653 | |a emergency prescribing | ||
653 | |a entrepreneurship | ||
653 | |a environment | ||
653 | |a fellowship | ||
653 | |a financial management | ||
653 | |a fragility | ||
653 | |a Germany | ||
653 | |a global health | ||
653 | |a health partnerships | ||
653 | |a health workforce | ||
653 | |a high fidelity | ||
653 | |a information gathering | ||
653 | |a internal medicine ward | ||
653 | |a interprofessional | ||
653 | |a intervention | ||
653 | |a Jazan | ||
653 | |a leadership | ||
653 | |a learning activity | ||
653 | |a levonorgestrel | ||
653 | |a Medicaid | ||
653 | |a Medicare | ||
653 | |a medication adherence | ||
653 | |a medication event monitoring system | ||
653 | |a medication review | ||
653 | |a medication safety | ||
653 | |a medication-related problems | ||
653 | |a medicine consumption | ||
653 | |a mortality | ||
653 | |a MUR | ||
653 | |a mystery calls | ||
653 | |a National Health Service (NHS) | ||
653 | |a non-prescription medicines | ||
653 | |a nonadherence | ||
653 | |a nursing | ||
653 | |a older adults | ||
653 | |a outcomes | ||
653 | |a pain | ||
653 | |a patient education | ||
653 | |a perception | ||
653 | |a pharmacist | ||
653 | |a pharmacists | ||
653 | |a pharmacogenomics | ||
653 | |a pharmacovigilance | ||
653 | |a pharmacy | ||
653 | |a pharmacy education | ||
653 | |a pharmacy law and regulation | ||
653 | |a pharmacy management | ||
653 | |a pharmacy practice | ||
653 | |a pharmacy students | ||
653 | |a polypharmacy | ||
653 | |a practice | ||
653 | |a pregabalin | ||
653 | |a prescription errors | ||
653 | |a prescription opioids | ||
653 | |a prescription writing | ||
653 | |a prescriptions | ||
653 | |a pricing | ||
653 | |a Program of All-Inclusive Care for the Elderly | ||
653 | |a reproductive health | ||
653 | |a Saudi Arabia | ||
653 | |a selecting pharmacy as a first choice | ||
653 | |a simulation | ||
653 | |a SPICE-R2 | ||
653 | |a standardized mortality ratio | ||
653 | |a standardized patients | ||
653 | |a student survey | ||
653 | |a students | ||
653 | |a systematic review | ||
653 | |a Taiwan | ||
653 | |a ulipristal acetate | ||
653 | |a underlying cause of death | ||
653 | |a unused medication | ||
653 | |a virtual learning | ||
793 | 0 | |a DOAB Library. | |
856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/91187 |7 0 |z Open Access: DOAB: description of the publication |
856 | 4 | 0 | |u https://mdpi.com/books/pdfview/book/5833 |7 0 |z Open Access: DOAB, download the publication |